STOCK TITAN
  1. Home
  2. Sec-filings
  3. CMND
  4. [EFFECT] Clearmind Medicine Inc. SEC Filing

[EFFECT] Clearmind Medicine Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 30, 2026
Accession Number: 0001213900-26-008227
Submission Type: POS AM
CIK: 0001892500
Company Name: Clearmind Medicine Inc.
File Number: 333-290404

Source: View Original Filing on SEC EDGAR

Stock CMND logo
Clearmind Medici

NASDAQ:CMND

CMND Rankings

#6868 Ranked by Market Cap
N/A Ranked by Dividends
#86 Top Loser

CMND Latest News

Feb 6, 2026
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
Feb 3, 2026
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
Jan 20, 2026
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
Jan 14, 2026
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
Dec 31, 2025
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement

CMND Latest SEC Filings

Feb 6, 2026
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Feb 4, 2026
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Feb 3, 2026
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Feb 2, 2026
[EFFECT] Clearmind Medicine Inc. SEC Filing
Feb 2, 2026
[EFFECT] Clearmind Medicine Inc. SEC Filing

CMND Stock Data

2.17M
1.10M
2.8%
10.96%
2.65%
Biotechnology
Healthcare
Link
Canada
Vancouver